AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
3
Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay
4
Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard
5
After Altera, is Intel preparing to sell Mobileye?
More news

Rating

5 stories about Rating
ראש הממשלה בנימין נתניהו 7.5.23

S&P to affirm Israel rating after Netanyahu guarantees firm to halt judicial overhaul

10.05.23|Adrian Filut
The prime minister was involved in talks with the representatives of the rating agency and promised that the judicial coup would not get passed in its original form
אתר טבע כפר סבא

Fitch Downgrades Teva, Keeps Outlook at Negative

10.06.19|Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
תל אביב קו רקיע Tel Aviv Skyline

High Government Debt Countered by Strong Finances Leads Fitch to Affirm Israel's A+ Rating

26.03.19|Lilach Baumer
Israel scores above the median on GDP growth and human development indicators, but low on government budget deficit, government debt, and ease of doing business
ירושלים הרי ירושלים כיפת הזהב מסגד אל אקצה

Moody's Upgrades Israel's Outlook to Positive

22.07.18|Omri Milman
The change was based on Israel’s favorable fiscal outcomes, strong institutional framework and on its “increasingly resilient economy”
מדענית ב מעבדת אבטחת איכות של חברת טבע TEVA

JPMorgan Downgrades Teva’s Stock to Underweight

13.11.17|Amarelle Wenkert
Christopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit